Reports

Below-the-Ankle Disease in Peripheral Artery Disease: Characteristics, Consequences and Prevalence. Review of Endovascular Revascularization

Peripheral Artery Disease: United States Endovascular Procedures by Site of Service 2015-2040

Peripheral Artery Disease: United States Endovascular Procedure Market by Disease Severity and Vascular Territory Aortoiliac, Femoropopliteal and Infrapopliteal 2015-2040

The Challenge of Infrapopliteal Disease: Characteristics, Restenosis After Endovascular Revascularization and Review of Several New Technologies

Peripheral Artery Disease in African Americans: Prevalence, Review of Disease Disparities and Causes of These Disparities: Why Do African Americans Have a Higher Prevalence of PAD and Why is the Disease More Severe?

Femoropopliteal Disease: Incidence of Restenosis After Endovascular Revascularization and Review of Cost-Effectiveness Analyses

Critical Limb Ischemia Non-Responders: Patients Who Do Not Respond to Revascularization, Factors That Identify Non-Response and Non-Responder Prevalence and Markets

The Cost of Critical Limb Ischemia

Thrombus in Peripheral Artery Disease (PAD): Prevalence and Market. A Significant But Recently Neglected Problem

Acute Limb Ischemia (ALI) U.S. Incidence and Market for Removal of Thrombi and Emboli

India – Peripheral Artery Disease and Critical Limb Ischemia 2018

United States – Critical Limb Ischemia by Rutherford Category Prevalence and Markets in Patients and Limbs 2017

China – Peripheral Artery Disease and Critical Limb Ischemia Prevalence and Incidence 2017

Japan – Peripheral Artery Disease and Critical Limb Ischemia Prevalence and Incidence 2017

Western Europe – Prevalence and Incidence of Peripheral Artery Disease and Critical Limb Ischemia 2017